首页> 美国卫生研究院文献>Breast Cancer Research : BCR >An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
【2h】

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

机译:最初的系统发育方法将线粒体单倍型T1a1与BRCA2突变携带者的乳腺癌风险呈负相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionIndividuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.
机译:简介在BRCA1和BRCA2基因中带有致病性突变的人有终身罹患乳腺癌的风险。 BRCA1和BRCA2参与DNA双链断裂修复,DNA改变可能是由于暴露于活性氧中引起的,而活性氧的主要来源是线粒体。线粒体基因组变异影响电子传输链效率和活性氧的产生。具有不同线粒体单倍型的个体在代谢和对氧化应激的敏感性方面有所不同。线粒体遗传背景的可变性会改变活性氧的产生,从而导致癌症风险。在本研究中,我们测试了线粒体单倍体修饰BRCA1 / 2突变携带者中乳腺癌风险的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号